V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003836 | 210011868 | null | null | null | null | 2020-05-07 | null | null | null | PALBOCICLIB | 100323428 |
| 210003838 | 210011869 | 1.55 | 90.3 | null | 2019-12-21 | 2021-10-28 | Eribulin | 02 | null | ERIBULIN | 101607323 |
| 210003844 | 210011870 | 1.58 | 47.3 | null | null | 2021-06-14 | Vinorelbine IV | null | null | VINORELBINE | 100348651 |
| 210003845 | 210011871 | 1.61 | 56.8 | null | 2021-07-13 | 2021-12-06 | CARBOPLATIN | null | null | CARBOPLATIN | 100474186 |
| 210003846 | 210011872 | 1.67 | 82.5 | Palliative (P) | null | 2016-06-27 | null | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 101408426 |
| 210003848 | 210011873 | 1.75 | 66 | Adjuvant (A) | 2018-07-26 | 2018-08-09 | Capecitabine | N | N | CAPECITABINE | 100349970 |
| 210003849 | 210011874 | 1.69 | 50.6 | Neo-adjuvant (N) | 2019-02-17 | 2019-02-18 | null | 02 | N | CARBOPLATIN + DOCETAXEL | 100363280 |
| 210003851 | 210011876 | 1.54 | null | null | 2020-02-02 | 2020-02-17 | FEC 60 or 75 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101793615 |
| 210003852 | 210011877 | 1.7 | 84.3 | Neo-adjuvant (N) | 2018-06-10 | 2018-07-03 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100647356 |
| 210003854 | 210011878 | null | null | Palliative (P) | 2021-07-22 | 2021-11-08 | Eribulin | 02 | N | ERIBULIN | 100202734 |
| 210003858 | 210011881 | 1.75 | 76.9 | null | 2014-05-11 | 2016-10-11 | null | 02 | null | EC | 101594501 |
| 210003864 | 210011884 | 1.63 | 69.3 | Neo-adjuvant (N) | 2019-04-11 | 2019-04-13 | null | null | N | CARBOPLATIN + GEMCITABINE | 100309071 |
| 210003868 | 210011885 | 1.68 | 55.2 | Neo-adjuvant (N) | 2020-08-11 | 2020-08-12 | Eribulin | 02 | N | ERIBULIN | 100115007 |
| 210003869 | 210011886 | 1.63 | 77.5 | Neo-adjuvant (N) | 2017-07-06 | 2017-07-24 | null | null | N | CAPECITABINE | 100691336 |
| 210003870 | 210011887 | 1.69 | 47.2 | 03 | 2019-09-11 | 2019-09-28 | EC | 02 | N | EC | 101050368 |
| 210003872 | 210011889 | null | 87.6 | null | 2021-10-05 | 2021-10-26 | PACLITAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | FEC | 100048535 |
| 210003874 | 210011890 | 1.62 | 85 | null | 2019-03-18 | 2019-06-11 | Pertuzumab (Maintenance) | 02 | null | PERTUZUMAB | 101181685 |
| 210003876 | 210011891 | 1.62 | 61.4 | Adjuvant (A) | 2018-02-24 | 2018-03-01 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100468627 |
| 210003877 | 210011892 | 1.96 | 69.7 | Neo-adjuvant (N) | 2020-04-08 | 2020-05-04 | Capecitabine | 02 | N | CAPECITABINE | 100632156 |
| 210003879 | 210011893 | 1.63 | 58 | null | null | 2021-11-27 | Letrozole + Palbociclib | 02 | null | LETROZOLE + PALBOCICLIB | 100017528 |
| 210000828 | 210011904 | 1.6 | 81.2 | null | 2021-02-11 | 2021-03-04 | Capecitabine | 02 | null | CAPECITABINE | 101773283 |
| 210000892 | 210011906 | 1.64 | 64.5 | Adjuvant (A) | 2017-04-30 | 2017-05-07 | ATEZOLIZUMAB + NAB PACLITAXEL | null | N | CARBOPLATIN + PACLITAXEL | 100248794 |
| 210000905 | 210011907 | 1.7 | 54.4 | null | 2017-05-06 | 2018-04-22 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101742852 |
| 210001086 | 210011908 | 1.76 | 65.4 | Palliative (P) | 2019-08-31 | 2019-08-31 | null | null | N | NAB-PACLITAXEL | 101663547 |
| 210001120 | 210011910 | 1.65 | 82.45 | null | 2019-02-10 | 2019-02-26 | EC | 02 | null | EC | 100823922 |
| 210001184 | 210011912 | null | 102.5 | null | null | 2017-08-02 | PERTUZUMAB + TRASTUZUMAB | N | null | PERTUZUMAB + TRASTUZUMAB | 100896768 |
| 210001402 | 210011914 | 1.7 | 81.8 | null | null | 2022-02-04 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101758627 |
| 210001443 | 210011915 | null | 72 | Palliative (P) | null | 2018-11-17 | null | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100966119 |
| 210001764 | 210011919 | 1.73 | 92.2 | null | 2021-07-07 | 2021-07-12 | Capecitabine | 02 | null | CAPECITABINE | 101177904 |
| 210001782 | 210011920 | 1.66 | 0 | null | 2021-03-13 | 2021-08-21 | Capecitabine | 02 | null | CAPECITABINE | 100854706 |
| 210002052 | 210011929 | 1.63 | 83.1 | null | 2020-10-28 | 2021-04-12 | Epirubicin (weekly) | 02 | null | LETROZOLE + PALBOCICLIB | 100843902 |
| 210002107 | 210011931 | 1.64 | 70.4 | Curative (C) | 2019-05-12 | 2019-05-18 | CARBOPLATIN + PACLITAXEL | 02 | N | ABEMACICLIB + FULVESTRANT | 101536240 |
| 210002127 | 210011932 | 1.56 | 67.8 | null | null | 2021-04-12 | Carboplatin AUC 6 - 10 | N | null | CARBOPLATIN | 100657281 |
| 210002229 | 210011934 | 1.55 | 0 | Neo-adjuvant (N) | null | 2020-03-03 | null | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101584469 |
| 210002260 | 210011935 | 1.7 | 59.9 | null | 2019-12-14 | 2020-03-08 | Paclitaxel albumin (Abraxane) 21day | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 101555067 |
| 210002362 | 210011937 | 1.66 | 56.6 | null | null | 2019-05-23 | ROSCO Trial | 02 | null | FEC + DOCETAXEL | 100908757 |
| 210002412 | 210011938 | null | null | Neo-adjuvant (N) | 2018-07-29 | 2018-07-31 | AC | null | N | EC | 100071313 |
| 210002431 | 210011939 | 1.66 | 86 | null | 2020-10-25 | 2020-11-30 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100024558 |
| 210002441 | 210011940 | 1.66 | 101.3 | Adjuvant (A) | null | 2017-01-23 | null | N | N | CARBOPLATIN + PACLITAXEL | 100246549 |
| 210002637 | 210011945 | 1.62 | 50.2 | Adjuvant (A) | null | 2020-05-24 | Capecitabine | null | N | CAPECITABINE | 101493616 |
| 210002751 | 210011946 | 1.66 | 62.8 | null | null | 2018-08-04 | Pertuzumab (Maintenance) | null | null | PERTUZUMAB | 100755182 |
| 210002805 | 210011947 | 1.49 | 0 | Neo-adjuvant (N) | 2017-03-27 | 2017-04-05 | Carboplatin + Docetaxel | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101615942 |
| 210002942 | 210011948 | 1.62 | 55.3 | null | 2019-12-02 | 2019-12-17 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101053988 |
| 210003252 | 210011952 | 0 | 52.2 | null | 2020-09-15 | 2022-01-28 | null | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL + TRASTUZUMAB | 101129757 |
| 210003466 | 210011955 | null | 57.8 | Neo-adjuvant (N) | null | 2021-10-16 | Capecitabine | 02 | N | CAPECITABINE | 100042368 |
| 210003521 | 210011958 | 1.62 | 73.7 | null | 2016-05-03 | 2019-01-16 | null | 02 | null | PACLITAXEL + TRASTUZUMAB | 100132424 |
| 210003548 | 210011959 | 1.56 | 69 | null | 2019-08-09 | 2019-08-23 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100525179 |
| 210003700 | 210011961 | 1.75 | 53.65 | Adjuvant (A) | null | 2018-06-19 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100539097 |
| 210003725 | 210011962 | 1.64 | 104.5 | Palliative (P) | 2019-11-04 | 2019-11-18 | VINORELBINE | null | N | VINORELBINE | 100388097 |
| 210003827 | 210011963 | 1.64 | 72.8 | Palliative (P) | 2022-02-25 | 2022-03-13 | null | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100114946 |